XML 53 R39.htm IDEA: XBRL DOCUMENT
v3.7.0.1

COMMON STOCK, STOCK OPTIONS AND WARRANTS (Details Narrative) |  |  | 1 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 12 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 09, 2017 $ / shares | Sep. 12, 2014 USD ($) Unit $ / shares shares | Jan. 31, 2017 shares | Oct. 31, 2016 Unit | Sep. 15, 2016 | Jul. 31, 2016 $ / shares shares | Jun. 23, 2016 Unit $ / shares shares | Mar. 30, 2016 USD ($) $ / shares shares | Oct. 31, 2015 Unit $ / shares shares | Mar. 31, 2017 USD ($) $ / shares shares | Mar. 31, 2016 USD ($) | Mar. 31, 2017 USD ($) Unit $ / shares shares | Mar. 31, 2016 USD ($) | Sep. 30, 2014 USD ($) $ / shares shares | Sep. 30, 2016 USD ($) Unit $ / shares shares | Sep. 30, 2015 USD ($) Unit $ / shares shares | Sep. 30, 2014 USD ($) Unit $ / shares shares | Aug. 16, 2016 $ / shares shares | Mar. 22, 2016 USD ($) $ / shares shares | May 31, 2014 USD ($) $ / shares shares | Dec. 31, 2013 USD ($)
Common Stock Par Value | $ / shares | $ 0.001 |  |  |  |  |  |  |  |  | $ 0.001 |  | $ 0.001 |  |  | $ 0.001 | $ 0.001 |  |  |  | $ 3.75 |
Common Stock Shares Issued |  |  | 29,729 |  |  |  |  |  |  | 5,033,616 |  | 5,033,616 |  | 866,667 | 4,875,871 | 2,274,526 | 866,667 |  |  | 13,333 |
Common stock | $ |  |  |  |  |  |  |  |  |  | $ 5,034 |  | $ 5,034 |  |  | $ 4,876 | $ 2,275 |  |  |  | $ 50,000 |
Reverse acquisition of common stock |  | 333,333 |  |  |  |  |  |  |  |  |  |  |  |  | 5,000,000 |  |  |  |  |  |
Description of increase in authorized shares of common stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Stockholders approved an increase in the number of shares of authorized common stock from 90,000,000 shares to 200,000,000 shares. |  |  |  |  |  |
Description of reverse stock split | 1-for-15 |  |  |  | Reverse stock split of our common stock by a ratio of not less than 1-for-8 and not more than 1-for-20 at any time prior to September 15, 2017. |  |  |  |  |  |  |  |  |  | Stockholders granted the Board of Directors the authority to effect a reverse stock split of our common stock by a ratio of not less than 1-for-8 and not more than 1-for-20 at any time prior to September 15, 2017. |  |  |  |  |  |
Deferred offering costs | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25,000
Banking agreement for raise cash | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5,100,000 |  |  | $ 5,100,000 |  |  |  |
Units issued to raise cash |  |  |  |  |  |  |  |  |  |  |  |  |  | 566,667 |  |  | 566,667 |  |  |  |
Stock-based compensation expense | $ |  |  |  |  |  |  |  |  |  | 300,030 | $ 115,614 | 541,544 | $ 236,913 | $ 470,185 | $ 732,151 | $ 486,271 |  |  |  |  |
Unrecognized total compensation cost related to unvested awards | $ |  |  |  |  |  |  |  |  |  | $ 883,760 |  | $ 883,760 |  |  |  |  |  |  |  |  |
Weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  | 18 months 36 days |  |  |  |  |  |  |  |  |
Weighted average options granted | $ / shares |  |  |  |  |  | $ 7.70 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options purchase |  |  |  |  |  | 138,267 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of increase in authorized shares of common stock |  |  |  |  | Stockholders approved an increase in the number of shares of authorized common stock from 90,000,000 shares to 200,000,000 shares. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of unit offering | Unit |  |  |  | 1,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock reserved for employees |  |  |  |  |  |  |  |  |  | 20,171,370 |  | 20,171,370 |  |  |  |  |  |  |  |  |
Options to purchase of common stock |  |  |  |  |  |  |  |  |  | 126,667 |  | 126,667 |  |  | 307,778 | 202,469 |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  | $ 9.00 |  | $ 9.00 |  |  | $ 9.00 |  |  |  |  |  |
Fair value of common stock | $ |  |  |  |  |  |  |  |  |  |  |  | $ 298,774 |  |  |  |  |  |  |  |  |
Share issued |  |  | 445,932 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock shares reserved for future issuance |  |  |  |  |  |  |  |  |  | 20,171,370 |  | 20,171,370 |  |  |  |  |  |  |  |  |
Stock Options [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock Shares Issued |  |  |  |  |  |  |  |  |  |  |  |  |  | 866,667 |  |  | 866,667 |  |  |  |
Common stock outstanding |  |  |  |  |  |  |  |  |  | 590,851 |  | 590,851 |  | 220,000 | 582,185 | 260,000 | 220,000 |  |  |  |
Shares available for future grants |  |  |  |  |  |  |  |  |  | 4,137,230 |  | 4,137,230 |  |  |  |  |  |  |  |  |
Stock-based compensation expense | $ |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 470,185 | $ 486,271 | $ 732,151 |  |  |  |  |
Unrecognized total compensation cost related to unvested awards | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,510,923 |  |  |  |  |  |
Weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 year 8 months 1 day | 5 years | 10 years |  |  |  |
Stock options granted |  |  |  |  |  |  |  | 6,035 | 26,667 |  |  |  |  |  |  | 6,667 | 220,000 |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  |  |  | $ 13.65 | $ 8.10 |  |  |  |  | $ 6.75 |  | $ 0.60 | $ 6.75 |  |  |  |
Weighted average options granted | $ / shares |  |  |  |  |  |  |  |  | $ 4.17 |  |  |  |  |  |  | $ 4.10 | $ 5.15 |  |  |  |
Number of directors | Unit |  |  |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |  |  |  |  |
Stock options vested |  |  |  |  |  |  |  | 72,423 |  |  |  |  |  |  |  |  |  |  |  |  |
Estimated fair value | $ |  |  |  |  |  |  |  | $ 670,242 |  |  |  |  |  |  |  |  |  |  |  |  |
Options to purchase of common stock |  |  |  |  |  |  |  |  |  |  |  |  |  | 590,851 |  |  | 590,851 |  |  |  |
Stock Options [Member] | Stock Incentive Plan 2014 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock Shares Issued |  |  |  |  |  |  |  |  |  |  |  |  |  | 275,816 |  |  | 275,816 |  |  |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock outstanding |  |  |  |  |  |  |  |  |  | 1,344,759 |  | 1,344,759 |  |  | 1,203,940 |  |  |  |  |  |
Intrinsic value of warrant | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,273,985 |  |  |  |  |  |
Weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3 years 9 months 7 days |  |  |  |  |  |
Stock options purchase |  |  |  |  |  |  |  | 243,020 |  |  |  |  |  |  |  |  |  | 66,667 |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3.00 |  |  |
Offering Warrants 2016 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock outstanding |  |  |  |  |  |  |  |  |  | 128,017 |  | 128,017 |  |  |  |  |  |  |  |  |
Weighted average remaining life |  |  |  |  |  |  |  |  |  |  |  | 3 years 5 months 5 days |  |  |  |  |  |  |  |  |
Number of units sold | Unit |  |  |  |  |  |  |  |  |  |  |  | 587,592 |  |  |  |  |  |  |  |  |
Other cash expenses related to private placement | $ |  |  |  |  |  |  |  |  |  |  |  | $ 176,896 |  |  |  |  |  |  |  |  |
Common stock sale prise | $ / shares |  |  |  |  |  |  |  |  |  | $ 6.00 |  | $ 6.00 |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  |  |  |  |  | $ 8.25 |  | $ 8.25 |  |  |  |  |  |  |  |  |
Estimated fair value | $ |  |  |  |  |  |  |  |  |  | $ 58,759 |  | $ 58,759 |  |  |  |  |  |  |  |  |
Stock sold |  |  |  |  |  |  |  |  |  | 128,017 |  | 128,017 |  |  |  |  |  |  |  |  |
Stock sold for gross proceeds | $ |  |  |  |  |  |  |  |  |  | $ 768,100 |  | $ 768,100 |  |  |  |  |  |  |  |  |
Number of unit offering per share price | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 0.40 |  |  |  |  |  |  |  |  |
Percentage of cash commission on gross proceeds |  |  |  |  |  |  |  |  |  |  |  | 0.10 |  |  |  |  |  |  |  |  |
Additional warrant purchase |  |  |  |  |  |  |  |  |  |  |  | 12,802 |  |  |  |  |  |  |  |  |
Warrant offering description |  |  |  |  |  |  |  |  |  |  |  | an expense allowance equal to 3% of the proceeds of the sale, and (ii) warrants to purchase a number of shares of common stock equal to 10% of the 2016 Offering Units sold at an exercise price of $0.55 per share. |  |  |  |  |  |  |  |  |
Warrants outstanding |  |  |  |  |  |  |  |  |  | 210,000 |  | 210,000 |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  | $ 8.25 |  | $ 8.25 |  |  |  |  |  |  |  |  |
Expense allowance | $ |  |  |  |  |  |  |  |  |  |  |  | $ 99,853 |  |  |  |  |  |  |  |  |
Placement Agent Unit Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock outstanding |  |  |  |  |  |  |  |  |  | 45,334 |  | 45,334 |  |  | 45,334 |  |  |  |  |  |
Number of units sold, per unit | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 0.40 |  |  |  |  |  |  |  |  |
Number of units sold | Unit |  |  |  |  |  |  |  |  |  |  |  | 1,920,250 |  |  |  |  |  |  |  |  |
Additional warrant purchase |  |  |  |  |  |  |  |  |  |  |  | 192,025 |  |  |  |  |  |  |  |  |
Warrant offering description |  |  |  |  |  |  |  |  |  |  |  | Company sold 1,920,250 2016 Offering Units, at a price of $0.40 per Unit, consisting of (i) one share of common stock and (ii) a warrant to purchase one share of common stock. Each 2016 Offering Warrant has an exercise price of $0.55 and is exercisable for five years from the date of issuance. |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  |  |  | $ 9.00 |  | $ 9.00 |  |  | $ 9.00 |  |  |  |  |  |
Private Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares available for future grants |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 284,482 |  |  |  |  |  |
Number of additional units sold | Unit |  |  |  |  |  |  |  |  |  |  |  | 1,000,000 |  |  | 290,000 | 189,136 | 66,667 |  |  |  |
Number of units sold, per unit | $ / shares |  | $ 9.00 |  |  |  |  |  |  |  |  |  |  |  |  | $ 8.10 | $ 8.10 | $ 0.60 |  |  |  |
Number of units sold | Unit |  | 226,671 |  |  |  |  |  |  |  |  |  |  |  |  | 17,778 | 13,333 |  |  |  |  |
Number of additional units sold, per unit | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 0.60 |  |  | $ 9.00 | $ 9.00 | $ 9.00 |  |  |  |
Number of units sold for gross proceeds | $ |  | $ 2,040,040 |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,509,000 | $ 1,652,000 | $ 2,040,040 |  |  |  |
Placement Agent paid commissions and expenses | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,229,124 | 741,058 | 265,206 |  |  |  |
Other cash expenses related to private placement | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 81,312 | 142,507 | $ 169,000 |  |  |  |
Derivative warrant liability | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,198,564 | $ 768,435 |  |  |  |  |
Common stock sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5,000,000 |  |  |  |  |  |
Common stock sale prise | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.60 |  |  |  | $ 9.00 |  |
Common stock, value, Outstanding | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 582,185 |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  | $ 0.015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Description of warrant redeemable |  | Common stock has traded for twenty (20) consecutive trading days with a closing price of at least $22.50 per share with an average trading volume of 3,333 shares per day and (ii) the Company provides 20 trading days prior notice of the redemption and the closing price of the common stock is not less than $17.55 for more than any 3 days during such notice period and (iii) the underlying shares of common stock are registered. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 333,333 |  |
Stock sold for gross proceeds | $ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,000,000 |  |
Exercise price of warrants | $ / shares |  | $ 9.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Four Director [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  |  | $ 12.00 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Weighted average options granted | $ / shares |  |  |  |  |  |  | $ 6.58 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of directors | Unit |  |  |  |  |  |  | 4 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options purchase |  |  |  |  |  |  | 13,333 |  |  |  |  |  |  |  |  |  |  |  |  |  |
LMB [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock Shares Issued |  |  |  |  |  |  |  | 1,942,456 |  | 1,942,456 |  | 1,942,456 |  |  | 1,942,456 |  |  |  |  |  |
Weighted average remaining life |  |  |  |  |  |  |  | 10 years |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options granted |  |  |  |  |  |  |  | 171,217 |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  |  |  | $ 0.015 |  |  |  |  |  |  |  |  |  |  |  |  |
Stock options purchase |  |  |  |  |  |  |  | 77,252 |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value vested options | $ |  |  |  |  |  |  |  | $ 461,808 |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value unvested options | $ |  |  |  |  |  |  |  | $ 461,808 |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  | $ 10.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Minimum [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  | $ 6.15 |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock exercise price per share | $ / shares |  |  |  |  |  | $ 13.50 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Maximum [Member] | Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants | $ / shares |  |  |  |  |  |  |  | $ 20.70 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Additional warrant purchase. + References No definition available. + Details
Name: | CTXR_AdditionalWarrantPurchase
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_AgreementForRaiseCashToInvestmentBank
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Derivative warrant liability. + References No definition available. + Details
Name: | CTXR_DerivativeWarrantLiability
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Description of increase in authorized shares of common stock. + References No definition available. + Details
Name: | CTXR_DescriptionOfIncreaseInAuthorizedSharesOfCommonStock
Namespace Prefix: | CTXR_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of warrant redeemable. + References No definition available. + Details
Name: | CTXR_DescriptionOfWarrantRedeemable
Namespace Prefix: | CTXR_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_FairValueOfCommonStock
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_FairValueUnvestedOptions
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_IntrinsicValueOfWarrant
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References No definition available. + Details
Name: | CTXR_NumberOfAdditionalUnitsSold
Namespace Prefix: | CTXR_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_NumberOfAdditionalUnitsSoldPerUnit
Namespace Prefix: | CTXR_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_NumberOfDirectors
Namespace Prefix: | CTXR_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of unit offering. + References No definition available. + Details
Name: | CTXR_NumberOfUnitOffering
Namespace Prefix: | CTXR_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_NumberOfUnitOfferingPerSharePrice
Namespace Prefix: | CTXR_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_NumberOfUnitsSold
Namespace Prefix: | CTXR_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of units sold for gross proceeds. + References No definition available. + Details
Name: | CTXR_NumberOfUnitsSoldForGrossProceeds
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_NumberOfUnitsSoldPerUnit
Namespace Prefix: | CTXR_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Other cash expenses related to private placement. + References No definition available. + Details
Name: | CTXR_OtherCashExpensesRelatedToPrivatePlacement
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_OutstandingWarrantsToPurchaseOfItsCommonStock
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage of cash commission on gross proceeds. + References No definition available. + Details
Name: | CTXR_PercentageOfCashCommissionOnGrossProceeds
Namespace Prefix: | CTXR_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | duration

X
- Definition Placement Agent paid commissions and expenses. + References No definition available. + Details
Name: | CTXR_PlacementAgentPaidCommissionsAndExpenses
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Reverse acquisition of common stock. + References No definition available. + Details
Name: | CTXR_ReverseAcquisitionOfCommonStock
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Shares available for future grants. + References No definition available. + Details
Name: | CTXR_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsFutureGrants
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | CTXR_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm4
Namespace Prefix: | CTXR_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | CTXR_StockOptionsPurchase
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | CTXR_StockOptionsVested
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Stock sold for gross proceeds. + References No definition available. + Details
Name: | CTXR_StockSoldForGrossProceeds
Namespace Prefix: | CTXR_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Units issued to raise cash. + References No definition available. + Details
Name: | CTXR_UnitsIssuedToRaiseCash
Namespace Prefix: | CTXR_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | CTXR_WarrantOfferingDescription
Namespace Prefix: | CTXR_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate number of common shares reserved for future issuance. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockCapitalSharesReservedForFutureIssuance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockValueOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of issuance costs recognized in a share-lending arrangement entered into by the entity, in contemplation of a convertible debt offering or other financing, after deduction of accumulated amortization or the effects of subsequent adjustments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 2A -URI http://asc.fasb.org/extlink&oid=7656903&loc=SL6757479-112611 + Details
Name: | us-gaap_DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Unrecognized cost of unvested share-based compensation awards. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value portion of investments accounted under the equity method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 25 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=66022186&loc=d3e32014-111567 + Details
Name: | us-gaap_EquityMethodInvestmentsFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of excess stock shares of an entity that have been sold or granted to shareholders. + References No definition available. + Details
Name: | us-gaap_ExcessStockSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Net number of non-option equity instruments granted to participants. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of options outstanding, including both vested and non-vested options. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(i)-(ii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of share instruments newly issued under a share-based compensation plan. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Information regarding derivative transactions entered into in connection with the issuance of contingently convertible securities that may be useful in explaining the potential impact of the contingently convertible securities. This information may include the terms of the derivative transaction (including settlement terms), how the transactions relate to the contingently convertible securities, and the number of shares underlying the derivatives. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 + Details
Name: | us-gaap_StockholdersEquityNoteDerivativeTransactionsConnectedWithContingentlyConvertibleSecurities
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB Topic 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 + Details
Name: | us-gaap_StockholdersEquityReverseStockSplit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of increase in the allowances and reserves, which consist of the valuation and qualifying accounts that are either netted against the cost of an asset or that reflect a liability established to represent expected future costs, from charges to costs and expenses. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-09) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24092-122690 + Details
Name: | us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_StockOptionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_StockCompensationPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=CTXR_OfferingWarrantsTwoThousandSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=CTXR_PlacementAgentUnitWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=CTXR_FourDirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=CTXR_LeonardMeronBiosciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |